Your browser doesn't support javascript.
loading
Interleukin-17A educated hepatic stellate cells promote hepatocellular carcinoma occurrence through fibroblast activation protein expression.
Ni, Jun-Sheng; Fu, Si-Yuan; Wang, Zong-Yan; Ding, Wen-Bin; Huang, Jian; Guo, Xing-Gang; Gu, Fang-Ming.
Affiliation
  • Ni JS; The Third Department of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Fu SY; The Third Department of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Wang ZY; The Third Department of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Ding WB; The Third Department of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Huang J; The Third Department of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Guo XG; The Third Department of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Gu FM; The Third Department of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
J Gene Med ; 26(6): e3693, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38860366
ABSTRACT

BACKGROUND:

Liver cancer is typified by a complex inflammatory tumor microenvironment, where an array of cytokines and stromal cells orchestrate a milieu that significantly influences tumorigenesis. Interleukin-17A (IL-17A), a pivotal pro-inflammatory cytokine predominantly secreted by Th17 cells, is known to play a substantial role in the etiology and progression of liver cancer. However, the precise mechanism by which IL-17A engages with hepatic stellate cells (HSCs) to facilitate the development of hepatocellular carcinoma (HCC) remains to be fully elucidated. This investigation seeks to unravel the interplay between IL-17A and HSCs in the context of HCC.

METHODS:

An HCC model was established in male Sprague-Dawley rats using diethylnitrosamine to explore the roles of IL-17A and HSCs in HCC pathogenesis. In vivo overexpression of Il17a was achieved using adeno-associated virus. A suite of molecular techniques, including RT-qPCR, enzyme-linked immunosorbent assays, Western blotting, cell counting kit-8 assays and colony formation assays, was employed for in vitro analyses.

RESULTS:

The study findings indicate that IL-17A is a key mediator in HCC promotion, primarily through the activation of hepatic progenitor cells (HPCs). This pro-tumorigenic influence appears to be mediated by HSCs, rather than through a direct effect on HPCs. Notably, IL-17A-induced expression of fibroblast activation protein (FAP) in HSCs emerged as a critical factor in HCC progression. Silencing Fap in IL-17A-stimulated HSCs was observed to reverse the HCC-promoting effects of HSCs.

CONCLUSIONS:

The collective evidence from this study implicates the IL-17A/FAP signaling axis within HSCs as a contributor to HCC development by enhancing HPC activation. These findings bolster the potential of IL-17A as a diagnostic and preventative target for HCC, offering new avenues for therapeutic intervention.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Interleukin-17 / Hepatic Stellate Cells / Liver Neoplasms Limits: Animals / Humans / Male Language: En Journal: J Gene Med Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Interleukin-17 / Hepatic Stellate Cells / Liver Neoplasms Limits: Animals / Humans / Male Language: En Journal: J Gene Med Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2024 Document type: Article Affiliation country:
...